Dabur India posts Q1 FY24 PAT at Rs. 463.88 Cr

The company has posted net profit of Rs. 463.88 crores for the period ended June 30, 2023

Lupin posts Q1 FY24 consolidated PAT at Rs. 452.26 Cr

The company has reported total income of Rs. 4836.89 crores during the period ended June 30, 2023

Piramal Pharma posts Q1 FY24 consolidated loss at Rs. 98.58 Cr

The company has reported total income of Rs. 1787.16 crores during the period ended June 30, 2023

Jagsonpal Pharmaceuticals posts Q1 FY2024 PAT at Rs. 7.47 Cr

The company has reported total income of Rs. 62.15 crores during the period ended June 30, 2023

Narayana Hrudayalaya posts Q1 FY24 consolidated PAT at Rs. 183.95 Cr

The company has reported total income of Rs. 1248.51 crores during the period ended June 30, 2023

Thyrocare Technologies posts Q1 FY24 PAT at Rs. 17.30 Cr

The company has reported total income of Rs. 135.87 crores during the period ended June 30, 2023

Bliss GVS Pharma Q1 FY2024 consolidated PAT up at Rs. 14.68 Cr

The company has reported total income of Rs. 164.63 crores during the period ended June 30, 2023

Concord Biotech’s IPO to open on 4th August, 2023

The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.

USFDA accepts biologics license application for GC Biopharma's GC5107B

Dr. Reddy's Laboratories Q1 FY2024 consolidated PAT jumps to Rs. 1402.5 Cr

The company has reported total income of Rs. 6738.4 crores during the period ended June 30, 2023